PMID: 7539530May 1, 1995Paper

Targeting of phototoxic drugs to antigen-specific T lymphocytes in vitro using antigen-presenting cell membranes

Photochemistry and Photobiology
N H ChangJ M Boggs

Abstract

We have used the complex of antigen with class II major histocompatibility proteins (Ia) in membrane-bound form to target a phototoxic compound to antigen-specific T cell hybridomas in vitro. The iodoacetamidyl ester of phototoxic pyrene was bound covalently to antigen-presenting cells (APC), and protein antigens were added to the cells for processing, presentation and targeting of the drug to three different T hybridomas specific for myelin basic protein (MBP), ovalbumin (OVA) and keyhole limpet hemocyanin (KLH). The B hybridoma LS102.9 was used as APC to present MBP, KLH and either a tryptic digest of OVA or the synthetic peptide OVA323-339 to these T cells. A transformed B lymphoma, which expresses trinitrophenol (TNP)-specific surface IgM, A20-HL, was used to present TNP conjugates of KLH and OVA to T cells. Either the antigen-bearing intact APC or Ia+ membranes shed spontaneously from them were used as drug carriers to target pyrene to the T cells. In the dark, or in the absence of pyrene, both the intact APC or the shed membranes stimulated interleukin-2 (IL-2) production by the T cells in an antigen-specific way. After UVA (320-400 nm) irradiation, both forms of these drug carriers had an antigen-specific toxic effect on...Continue Reading

References

Jan 1, 1992·Cancer Immunology, Immunotherapy : CII·T Berki, P Németh
Jan 1, 1990·Current Problems in Dermatology·R L Edelson
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·A R OseroffM L Yarmush
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·M WatanabeN Hozumi
Feb 1, 1988·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J R MurphyT B Strom
Nov 1, 1988·Immunology Today·I R Cohen, H L Weiner
Jan 1, 1987·The Journal of Experimental Medicine·J D AshwellD Hernandez
Aug 1, 1983·The Journal of Experimental Medicine·R ShimonkevitzH Grey
Aug 1, 1982·The Journal of Experimental Medicine·D J VolkmanD M Neville
Jun 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·J KapplerP Marrack

❮ Previous
Next ❯

Citations

Mar 9, 2010·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Melania Babincova, Peter Babinec

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.